News Focus
News Focus
Replies to #59800 on Biotech Values
icon url

genisi

09/04/08 9:22 AM

#65830 RE: DewDiligence #59800

From Novartis' analyst meeting -
Sandoz has 25 biosimilars in varying stages of development and 110 ongoing difficult-to-make generics projects. Sandoz believes US guidance for biosimilars is near-term.